Cohen Ken R, Vabson Boris, Podulka Jennifer, Smith Nathan J, Everhart Erica, Ameli Omid, Catlett Kierstin, Jarvis Megan S, Goldzweig Caroline, Kuo Julie H, Dentzer Susan
Optum Center for Research and Innovation, Minnetonka, Minnesota.
Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.
JAMA Netw Open. 2025 Jan 2;8(1):e2456074. doi: 10.1001/jamanetworkopen.2024.56074.
Many physician groups are in 2-sided risk payment arrangements with Medicare Advantage plans (at-risk MA). Analysis of quality and health resource use under such arrangements may inform ongoing Medicare policy concerning payment and service delivery.
To compare quality and efficiency measures under 2 payment models: at-risk MA and fee-for-service (FFS) MA.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used Medicare encounter and enrollment data from 2016 to 2019 covering 17 physician groups, 15 488 physicians, and 35 health insurers to compare quality and health resource use for Medicare beneficiaries within the same physician groups. The data were analyzed between August 4 and October 30, 2024.
Care delivered under at-risk MA and FFS MA payment arrangements by the same physicians and medical groups.
Twenty quality and efficiency measures across 4 domains of patient care (hospital care, avoidance of the emergency department [ED], avoidance of disease-specific admissions, and outpatient care) were examined using logistic regression analysis.
The overall sample comprised 5 278 717 person-years (37.7% at-risk MA and 62.3% FFS MA). The mean (SD) age of beneficiaries was 73.6 (9.2) years in the at-risk MA group (56.8% women) and 71.8 (10.4) years in the FFS MA group (57.4% women). For at-risk MA compared with FFS MA, inpatient admissions and 30-day readmissions per 1000 were 10.03 (95% CI, -10.61 to -9.44) and 1.95 (95% CI, -2.18 to -1.73) lower. ED use measures per 1000 ranged from 2.95 (95% CI, -3.28 to -2.63) lower for avoidable ED visits to 26.02 (95% CI, -26.92 to -25.12) lower for overall ED visits. Avoidance of disease-specific admissions per 1000 ranged from 0.24 (95% CI, -0.35 to -0.13) lower for composite diabetes-related admissions to 2.18 (95% CI, -2.43 to -1.94) lower for the composite of chronic disease-related admissions. High-risk drug use per 1000 was 14.26 (95% CI, -14.85 to -13.67) lower. Overall, compared with FFS MA, at-risk MA was associated with higher quality and efficiency in 18 of 20 measures after adjusting for differences in demographics, Hierarchical Condition Categories Risk Adjustment Factor scores, and other health characteristics.
In this cross-sectional study, at-risk MA payment arrangements managed by physician groups were associated with higher quality and efficiency compared with FFS MA managed by the same groups. The population and methods used provide robust evidence that at-risk payment arrangements in MA may improve health care delivery for the MA population.
许多医师团体与医疗保险优势计划(风险调整型医疗保险优势计划)存在双边风险支付安排。对此类安排下的质量和卫生资源使用情况进行分析,可能为医疗保险现行的支付和服务提供政策提供参考。
比较两种支付模式下的质量和效率指标:风险调整型医疗保险优势计划和按服务收费的医疗保险优势计划。
设计、设置和参与者:这项横断面研究使用了2016年至2019年医疗保险就诊和参保数据,涵盖17个医师团体、15488名医师和35家健康保险公司,以比较同一医师团体内医疗保险受益人的质量和卫生资源使用情况。数据于2024年8月4日至10月30日进行分析。
同一医师和医疗团体在风险调整型医疗保险优势计划和按服务收费的医疗保险优势计划支付安排下提供的医疗服务。
使用逻辑回归分析检查了患者护理4个领域(住院护理、避免急诊就诊、避免特定疾病入院和门诊护理)的20项质量和效率指标。
总体样本包括5278717人年(37.7%为风险调整型医疗保险优势计划,62.3%为按服务收费的医疗保险优势计划)。风险调整型医疗保险优势计划组受益人的平均(标准差)年龄为73.6(9.2)岁(女性占56.8%),按服务收费的医疗保险优势计划组为71.8(10.4)岁(女性占57.4%)。与按服务收费的医疗保险优势计划相比,风险调整型医疗保险优势计划每1000人的住院入院和30天再入院率分别低10.03(95%置信区间,-10.61至-9.44)和1.95(95%置信区间,-2.18至-1.73)。每1000人的急诊使用指标范围从可避免急诊就诊低2.95(95%置信区间,-3.28至-2.63)到总体急诊就诊低26.02(95%置信区间,-26.92至-25.12)。每1000人避免特定疾病入院率范围从糖尿病综合相关入院低0.24(95%置信区间,-0.35至-0.13)到慢性病综合相关入院低2.18(95%置信区间,-2.43至-1.94)。每1000人的高风险药物使用率低14.26(95%置信区间,-14.85至-13.67)。总体而言,在调整人口统计学差异、分层条件类别风险调整因子得分和其他健康特征后,与按服务收费的医疗保险优势计划相比,风险调整型医疗保险优势计划在20项指标中的18项上与更高的质量和效率相关。
在这项横断面研究中,与同一团体管理的按服务收费的医疗保险优势计划相比,医师团体管理的风险调整型医疗保险优势计划支付安排与更高的质量和效率相关。所使用的人群和方法提供了有力证据,表明医疗保险优势计划中的风险调整型支付安排可能改善医疗保险优势计划人群的医疗服务提供。